Gidazepam

Gidazepam is an atypical benzodiazepine developed in the Soviet Union, licensed for use in Russia and Ukraine under the brand name Gidazepam IC. It functions as a prodrug metabolized to desalkylgidazepam (bromo-nordazepam). Unlike typical benzodiazepines, gidazepam has minimal sedative and hypnotic effects, making it suitable for daytime use. It has a uniquely delayed onset (30-60 minutes) and exceptionally long half-life (86-87 hours). Therapeutic doses range from 60-200 mg daily, divided into 2-3 doses.

Also known as: Hydazepam, Gidazepam ic, Hidazepam, Gidazepam monohydrate

Classification

Chemical: Benzodiazepine
Chemical: Medicine
Psychoactive: Depressant
Tag: Anxiolytic
Tag: GABAergic
Tag: Muscle Relaxant

Effects

Muscle Relaxation
Physical Euphoria
Sedation
Stimulation
Fatigue
Anxiety Suppression
Cognitive Clarity
Emotion Suppression
Euphoria
Memory Impairment
Amnesia
Disinhibition
Dulled Perception

Routes of Administration

Oral

Dosage

Threshold: 5 mg
Light: 10-20 mg
Common: 20-50 mg
Strong: 50-70 mg
Heavy: 70+ mg

Duration

Onset: 0.5-1 h
Comeup: 1-2 h
Peak: 1-4 h
Offset: 6-12 h
After Effects: 12-36 h
Total Duration: 12-48 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

dose.wiki

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu